The Department of Veterans Affairs (VA), Veterans Health Administration, Network Contracting Office 17, has awarded a firm-fixed-price Indefinite Delivery Contract (IDC) to Karius, Inc., a life sciences company specializing in diagnostic services for infectious diseases. The IDC, valued at $600,000 and effective through July 31, 2027, allows the VA to purchase next-generation sequencing (NGS) tests from Karius at $2,000 per test.
Karius has been identified as the sole responsible source capable of meeting the VA's specific requirements for the Karius TestA, a proprietary NGS blood test that can detect over 1,000 pathogens from a single sample. This sole-source procurement was conducted under the statutory authority of 41 U.S.C. 3304(a)(1) and implemented through FAR 6.302-1. Multiple delivery orders have been issued against the IDC, including task orders for laboratory testing services at the Orlando VA Medical Center and general NGS testing, demonstrating Karius' strategic partnership with the VA in supporting healthcare services for veterans.
Generated 3/21/25, 9:45 AM